Css LLC Clovis Oncology, Inc. Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.81 - $10.34 $168,508 - $362,241	-35,033 Reduced 85.38%	6,000 $42,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $199,263 - $339,343	35,020 Added 582.4%	41,033 $277,000
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $173,664 - $292,575	5,913 Added 5913.0%	6,013 $177,000
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $6,717 - $8,481	100	100 $8,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.